)
)
Heart Eye
CVD screening in line with NHS 10 year plan: Dr.Noon CVD is a CE-marked, MHRA-accredited AI screening software using already-available fundus imaging that detects cardiovascular risk by analysing subtle changes in retinal blood vessels, with accuracy comparable to CT imaging.
Developed in collaboration with leading cardiologists and featured by the European Society of Cardiology (2024) and the American Heart Association (2025), it enables early detection of cardiovascular disease, even in patients with no symptoms. Unlike QRISK3 and other similar traditional tools relying on statistical methods, Dr.Noon reveals risk that often go unnoticed through vessel visualisation.
Its insights are backed by over 50 peer-reviewed publications, including The Lancet, JAMIA, and the Journal of Insurance Medicine, where it’s been described as a “game-changer” in preventative screening.
What will be showcased on our stand?
Free heart health check from the eye. Live demonstration of cardiovascular screen with simple eye photograph. Report generated in real-time.